Stone Flower

Parmotrema perlatum
Stone Flower (Parmotrema perlatum), or Patthar Phool (Rock Flower), is a unique lichen revered in Ayurveda for its claimed cooling and astringent properties. Traditionally, it's supposedly beneficial for balancing Vata and Pitta doshas while increasing Kapha. This widely prevalent ingredient is often used in traditional formulations, particularly for its claimed digestive and detoxification support.
PLANT FAMILY
Parmeliaceae (Shield Lichen)
PARTS USED
Not a plant
AYURVEDIC ACTION
Vata ↓, Pitta ↓, Kapha ↑
ACTIVE COMPOUNDS
Lichen acids (0.1-0.5%)

What is Stone Flower?

Stone Flower, scientifically identified as Parmotrema perlatum, is a species of lichen belonging to the Parmeliaceae (Shield Lichen) family. Unlike typical plants, lichens are symbiotic organisms, a fascinating partnership between a fungus and an alga or cyanobacterium. This particular species is commonly found growing on rocks, trees, and soil, creating a distinctive, often leafy appearance.

Its unique structure and habitat underscore its biological classification as a non-plant organism, exhibiting a complex interplay of life forms. While not a conventional botanical entity, its presence is a testament to nature's intricate cooperative strategies, thriving in diverse, often harsh, environments across the globe.

Other Names of Stone Flower

  • Patthar Phool
  • Dagad Phool
  • Chhadila
  • Rock Moss

Benefits of Stone Flower

Heading

<h3> Absolute Contraindications of Stone Flower </h3> <h4> Known allergy to lichens / lichen acids (skin or respiratory allergy)</h4> <ul> <li>🧴</li> <li>Recommendation: Avoid using Stone Flower if you have a history of allergic contact dermatitis or respiratory allergy to lichens or fragrance ingredients; seek allergy testing if unsure.</li> <li>Reasoning: Several clinical reports document allergic contact dermatitis caused by lichen acids (eg, usnic acid and related lichen compounds). People who react to lichen extracts or oak-moss fragrances can develop rashes, and repeated exposure may trigger occupational dermatitis.</li> <li>Scientific_Study_Title: Allergy to lichens. Allergic contact dermatitis from usnic acid produced by lichenized fungi.</li> <li>Scientific_Study_Authors: J. C. Mitchell</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/11850913/</li> <li>Scientific_Study_Excerpt: <p>Mitchell reported two forest workers with clear patch-test positivity to lichens containing usnic acid and to isolated usnic acid, linking contact exposure to lichens with allergic contact dermatitis. The cases illustrated that lichen-derived acids can act as cutaneous allergens in susceptible people and produce occupational dermatitis. The authors note that lichens accumulate in forest environments and that sensitivity to lichen acids may be under-recognized, recommending avoidance by sensitized individuals.</p> </li> </ul> <h4> Concomitant use with strong calcium-channel blockers or other vasodilators (risk of additive hypotension)</h4> <ul> <li>💊</li> <li>Recommendation: Do not combine concentrated Stone Flower extracts with prescription calcium-channel blockers or potent vasodilators without physician guidance; if used in food amounts, monitor blood pressure closely.</li> <li>Reasoning: Pharmacological research on Parmotrema perlatum extract shows clear calcium-channel antagonism and vasodilatory activity in isolated blood vessel preparations. Combining two agents with similar vasodilatory mechanisms can cause excessive blood-pressure lowering or symptomatic hypotension.</li> <li>Scientific_Study_Title: The spasmolytic, bronchodilator, and vasodilator activities of Parmotrema perlatum are explained by anti-muscarinic and calcium antagonistic mechanisms.</li> <li>Scientific_Study_Authors: M. Ahmad, H. et al. (article authors listed on PubMed entry)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/34770756/</li> <li>Scientific_Study_Excerpt: <p>In isolated aortic rings and other smooth-muscle preparations, the crude extract of Parmotrema perlatum produced concentration-dependent relaxation comparable to verapamil and other calcium-channel blockers. The study demonstrates that the extract shifts calcium concentration-response curves to the right, consistent with Ca2+ antagonism, and also shows vasorelaxant effects against phenylephrine-induced contraction. The authors conclude that calcium-channel antagonism likely underlies the observed vasodilatory action, implying potential additive effects with pharmaceutical vasodilators.</p> </li> </ul> <h4> Pre-existing severe liver disease / concurrent use of known hepatotoxic botanical preparations</h4> <ul> <li>⚠️</li> <li>Recommendation: Avoid concentrated lichen extracts if you have chronic liver disease or are taking other hepatotoxic agents; consult a hepatologist before any use.</li> <li>Reasoning: Certain lichen secondary metabolites (notably usnic acid in some lichen species) have been linked to idiosyncratic severe liver injury in humans. Although not all Parmotrema samples contain usnic acid, the family of lichen compounds has documented hepatotoxic risk in supplements.</li> <li>Scientific_Study_Title: Introduction - NTP Technical Report on the Toxicity Studies of (+)-Usnic Acid administered in feed to rats and mice.</li> <li>Scientific_Study_Authors: National Toxicology Program (NTP) contributors / review compendium (multi-author NTP report)</li> <li>Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/books/NBK104/ (NTP technical and review literature on usnic acid)</li> <li>Scientific_Study_Excerpt: <p>Regulatory and case-report literature summarized by NTP and related reviews documents multiple human cases of severe liver injury associated with dietary supplements containing (+)-usnic acid, including products withdrawn after reports of fulminant hepatitis and liver transplant needs. Experimental toxicity studies and human adverse event surveillance indicate that high-dose ingestion of usnic acid can result in hepatocellular necrosis and acute liver failure in susceptible individuals, supporting caution with lichen products that may contain hepatotoxic metabolites.</p> </li> </ul> <h4> Risk from source contamination (heavy metals) - vulnerable populations (pregnancy, young children, renal impairment)</h4> <ul> <li>🧪</li> <li>Recommendation: Avoid regular ingestion of wild-harvested Stone Flower from unknown sources if pregnant, breastfeeding, very young, elderly, or renally impaired; prefer tested, food-grade suppliers with contamination analysis.</li> <li>Reasoning: Lichens are well-documented bioaccumulators of airborne heavy metals and other environmental pollutants. Wild-collected lichen spices can therefore contain elevated metal residues depending on harvest location, posing potential risk to vulnerable groups.</li> <li>Scientific_Study_Title: Insight into the pattern of heavy-metal accumulation in lichen thalli.</li> <li>Scientific_Study_Authors: Authors of the 2020 study (see PubMed record)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/32299012/</li> <li>Scientific_Study_Excerpt: <p>Studies of lichen thalli across pollution gradients show that lichens accumulate toxic trace metals (eg, Pb, Cd) both extracellularly and intracellularly, with total tissue concentrations related to environmental exposure. The paper describes the patterns of accumulation and indicates that lichens can concentrate airborne metals over time, meaning that ingestion of lichen biomass collected from polluted areas could deliver measurable amounts of heavy metals to humans. The authors suggest that species and site differences influence metal loads and recommend considering contamination when lichens are used for food or medicine.</p> </li> </ul> <h3> Relative Contraindications of Stone Flower </h3> <h4> On prescription antidiabetic medication (risk of additive effect on post-meal glucose lowering)</h4> <ul> <li>🍬</li> <li>Recommendation: If you take prescription blood-sugar lowering drugs, discuss with your clinician before using Stone Flower regularly; monitor blood glucose if started.</li> <li>Reasoning: Compounds in Parmotrema genus have shown alpha-glucosidase inhibitory activity in vitro; combining such inhibition with oral hypoglycemic drugs could increase the risk of hypoglycemia post-meal.</li> <li>Scientific_Study_Title: α-Glucosidase inhibitory depsidones from the lichen Parmotrema tsavoense.</li> <li>Scientific_Study_Authors: Devi AP, Duong TH, Ferron S, et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/32483775/</li> <li>Scientific_Study_Excerpt: <p>Chemical investigation of Parmotrema tsavoense isolated several depsidone metabolites that were evaluated for α-glucosidase inhibition. The active compounds showed potent enzyme inhibition with IC50 values far below the control (acarbose), indicating strong potential to slow carbohydrate digestion. The authors discuss these depsidones as plausible contributors to traditional antidiabetic uses of Parmotrema lichens and note the pharmacological basis for potential interactions with antidiabetic therapies.</p> </li> </ul> <h4> Concurrent use with other antihypertensives (relative risk of low blood pressure)</h4> <ul> <li>💓</li> <li>Recommendation: Use cautiously with multiple blood-pressure medications; monitor blood pressure and symptoms if using concentrated preparations.</li> <li>Reasoning: Parmotrema perlatum extract displays calcium-channel antagonism and vasodilatory activity in experiments; when combined with prescription antihypertensives the effects may be additive.</li> <li>Scientific_Study_Title: The spasmolytic, bronchodilator, and vasodilator activities of Parmotrema perlatum are explained by anti-muscarinic and calcium antagonistic mechanisms.</li> <li>Scientific_Study_Authors: M. Ahmad, H. et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/34770756/</li> <li>Scientific_Study_Excerpt: <p>Experimental data show that crude P. perlatum extract produced a marked relaxation of K+- and phenylephrine-induced aortic contractions and shifted calcium response curves consistent with Ca2+ channel antagonism. The authors highlight vasodilatory effects that may explain traditional uses for hypertension and digestive spasm; they caution that pharmacodynamic overlap with prescription antihypertensives may produce additive hypotensive effects and recommend further study.</p> </li> </ul> <h4> Use during pregnancy or breastfeeding (due to limited safety data + contamination risk)</h4> <ul> <li>🤰</li> <li>Recommendation: Prefer to avoid medicinal or concentrated Stone Flower preparations during pregnancy and lactation unless advised by a qualified clinician and product is quality-tested; small culinary use is less likely to be harmful but verify source.</li> <li>Reasoning: There are no robust human safety trials on Parmotrema extracts in pregnancy or breastfeeding; combined with the risk of environmental contaminants in wild-harvested lichens, this supports a cautious approach for vulnerable populations.</li> <li>Scientific_Study_Title: Insight into the pattern of heavy-metal accumulation in lichen thalli.</li> <li>Scientific_Study_Authors: (see PubMed entry)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/32299012/</li> <li>Scientific_Study_Excerpt: <p>The study documents heavy-metal uptake patterns across lichen thalli sampled from different pollution contexts, noting that lichens can concentrate environmental metals and that levels vary by species and site. Because metals like lead and cadmium pose specific risks to fetal development and to young children, the authors recommend considering environmental contamination when lichens are used for any ingestion, which informs caution during pregnancy and lactation.</p> </li> </ul> <h4> Concurrent use with known hepatotoxic herbal supplements or raw usnic-containing preparations</h4> <ul> <li>⚠️</li> <li>Recommendation: Avoid combining concentrated lichen extracts with other supplements known to stress the liver (eg, high-dose usnic supplements historically linked to liver injury); check ingredient lists carefully and consult your clinician.</li> <li>Reasoning: Case series and regulatory reviews have linked ingestion of some lichen-derived metabolites (usnic acid) in supplements to severe acute liver injury; combining multiple hepatically active agents increases risk.</li> <li>Scientific_Study_Title: Introduction - NTP Technical Report on the Toxicity Studies of (+)-Usnic Acid.</li> <li>Scientific_Study_Authors: National Toxicology Program contributors / review compendium</li> <li>Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/books/NBK104/</li> <li>Scientific_Study_Excerpt: <p>Regulatory summaries and case reports examined by NTP and public health agencies recount multiple human cases of hepatotoxicity associated with diet aids and supplements containing (+)-usnic acid, some requiring liver transplantation. The literature emphasizes idiosyncratic severe hepatic reactions and supports avoiding co-administration of potentially hepatotoxic botanicals and careful monitoring when lichen-derived molecules are present.</p> </li> </ul>

Heading

<h4> Contact skin allergy / contact dermatitis</h4> <ul> <li>🩹</li> <li>Side effect summary: Some people exposed to lichens or lichen extracts develop allergic contact dermatitis (red, itchy rash) at sites of contact; fragrances containing lichen acids have been implicated in topical product reactions.</li> <li>Recommendation: Stop topical use immediately if a rash appears; seek dermatology input and consider patch testing for lichen acid sensitivity. Avoid further exposure if positive.</li> <li>Reasoning: Patch-test positive cases and occupational reports show that lichen acids (eg, usnic acid and related compounds) are capable of producing allergic contact reactions in sensitized individuals.</li> <li>Severity Level: Moderate</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Title: Allergy to lichens. Allergic contact dermatitis from usnic acid produced by lichenized fungi.</li> <li>Scientific_Study_Authors: J. C. Mitchell</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/11850913/</li> <li>Scientific_Study_Excerpt: <p>The author documents two forest workers with occupational dermatitis who had positive patch tests to lichens containing usnic acid and to purified usnic acid. Clinical presentation, testing and work history linked direct lichen exposure to skin inflammation. The report highlights that lichen acids can sensitize skin and cause dermatitis on contact, and that such reactions may be underrecognized outside occupational settings.</p> </li> </ul> <h4> Potential hepatotoxicity when high-dose usnic-containing products are used</h4> <ul> <li>🧾</li> <li>Side effect summary: High-dose ingestion of certain lichen metabolites (notably usnic acid in some species/products) has been associated with acute hepatitis and liver failure.</li> <li>Recommendation: Avoid using unlabelled or high-concentration lichen supplements; stop use and seek medical care if jaundice, dark urine, severe abdominal pain or extreme fatigue occur.</li> <li>Reasoning: Multiple human case reports and regulatory alerts link supplements containing usnic acid to severe liver injury; while Parmotrema perlatum often contains other acids (eg, stictic, atranorin), the general class risk warrants caution with concentrated lichen products.</li> <li>Severity Level: Severe</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Title: Introduction - NTP Technical Report on the Toxicity Studies of (+)-Usnic Acid.</li> <li>Scientific_Study_Authors: National Toxicology Program contributors / compendium</li> <li>Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/books/NBK104/</li> <li>Scientific_Study_Excerpt: <p>Regulatory reviews and case series summarized by NTP report multiple adverse hepatic events associated with oral supplements containing (+)-usnic acid, including acute hepatitis, fulminant liver failure, and two cases requiring transplantation. The literature discusses idiosyncratic severe reactions and experimental evidence of mitochondrial toxicity as a mechanistic basis, supporting a high-severity classification for hepatotoxic outcomes linked to some lichen metabolites.</p> </li> </ul> <h4> Anticholinergic-type effects (mechanism-based; possible dry mouth, urinary retention)</h4> <ul> <li>😶‍🌫️</li> <li>Side effect summary: Because extracts show antimuscarinic activity in lab models, concentrated medicinal use could theoretically produce anticholinergic effects such as dry mouth, blurred vision or urinary hesitancy in susceptible individuals.</li> <li>Recommendation: If you have conditions worsened by antimuscarinic effects (glaucoma, prostate enlargement, urinary retention), avoid medicinal-strength Stone Flower extracts or discuss with your clinician before use.</li> <li>Reasoning: Isolated tissue studies demonstrate that Parmotrema perlatum extract behaves like antimuscarinic agents, blocking muscarinic-receptor mediated contractions; this pharmacology predicts possible anticholinergic side effects in vivo at sufficient doses.</li> <li>Severity Level: Mild</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Title: The spasmolytic, bronchodilator, and vasodilator activities of Parmotrema perlatum are explained by anti-muscarinic and calcium antagonistic mechanisms.</li> <li>Scientific_Study_Authors: M. Ahmad, H. et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/34770756/</li> <li>Scientific_Study_Excerpt: <p>In vitro pharmacological assays of P. perlatum crude extract caused right-shifted concentration-response curves to carbachol in jejunum and tracheal tissue, consistent with muscarinic receptor blockade. The authors compare the extract's effects with dicyclomine, a known antimuscarinic, suggesting that antimuscarinic pharmacology underlies spasmolytic and bronchodilator actions and could theoretically translate into anticholinergic adverse effects if exposures are large enough.</p> </li> </ul>

Heading

<h4> Calcium-channel blockers / other potent vasodilators (e.g., verapamil, amlodipine)</h4> <ul> <li>Interaction_Details: Parmotrema perlatum extract shows calcium-channel antagonism and vasodilatory effects in lab tissue studies; combining it with prescription calcium-channel blockers or strong vasodilators could produce additive blood-pressure lowering and symptomatic hypotension.</li> <li>Severity: Severe</li> <li>Recommendation: Avoid concurrent use of concentrated medicinal Stone Flower extracts with prescription calcium-channel blockers without medical supervision; if culinary amounts are used, monitor blood pressure and symptoms closely.</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/34770756/</li> <li>Scientific_Study_Title: The spasmolytic, bronchodilator, and vasodilator activities of Parmotrema perlatum are explained by anti-muscarinic and calcium antagonistic mechanisms.</li> <li>Scientfic_Study_Authors: M. Ahmad, H. et al.</li> <li>Scientific_Study_Excerpt: <p>Experimental data using isolated aortic rings and other smooth-muscle preparations show that crude P. perlatum extract relaxes K+- and phenylephrine-induced contractions and shifts Ca2+ response curves to the right, consistent with calcium-channel blockade. These pharmacodynamic properties are similar to those of verapamil and other Ca2+ antagonists, indicating a plausible risk of additive hypotensive effects if combined with clinical calcium-channel blockers.</p> </li> </ul> <h4> Drugs affecting post-prandial glucose (eg, acarbose, miglitol, sulfonylureas, insulin)</h4> <ul> <li>Interaction_Details: Compounds isolated from Parmotrema species inhibit alpha-glucosidase in vitro; co-administration with antidiabetic drugs could enhance glucose-lowering and increase hypoglycemia risk or alter glycemic control.</li> <li>Severity: Moderate</li> <li>Recommendation: People on antidiabetic medications should consult their prescribing clinician before using Stone Flower therapeutically; monitor blood glucose closely if started and adjust medication under medical supervision.</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/32483775/</li> <li>Scientific_Study_Title: α-Glucosidase inhibitory depsidones from the lichen Parmotrema tsavoense.</li> <li>Scientfic_Study_Authors: Devi AP, Duong TH, Ferron S, Beniddir MA, Dinh MH, Nguyen VK, et al.</li> <li>Scientific_Study_Excerpt: <p>Chemical isolation from Parmotrema tsavoense yielded depsidone metabolites that inhibited α-glucosidase with IC50 values markedly lower than acarbose, the positive control. The authors report potent in-vitro inhibition and discuss the potential of these metabolites to modulate carbohydrate digestion and post-prandial glycemia, indicating a plausible interaction with antidiabetic therapies and supporting caution when co-used.</p> </li> </ul> <h4> Concomitant use with other hepatotoxic agents or strong CYP inhibitors (risk of liver injury)</h4> <ul> <li>Interaction_Details: Although Parmotrema perlatum does not necessarily contain usnic acid, some lichen metabolites can cause liver injury; combining lichen extracts with other hepatotoxic botanicals or drugs (or with CYP inhibitors that alter metabolism) may increase hepatic risk.</li> <li>Severity: Severe</li> <li>Recommendation: Avoid combining unknown or concentrated lichen extracts with known hepatotoxic drugs or supplements; consult your clinician and check product testing for hepatotoxic lichen metabolites.</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/books/NBK104/</li> <li>Scientific_Study_Title: Introduction - NTP Technical Report on the Toxicity Studies of Usnic Acid.</li> <li>Scientfic_Study_Authors: National Toxicology Program contributors / compendium</li> <li>Scientific_Study_Excerpt: <p>Regulatory case summaries and toxicology reviews document multiple instances in which oral supplements containing (+)-usnic acid were associated with acute severe hepatic injury, sometimes requiring transplantation. The literature emphasizes idiosyncratic hepatotoxic potential and identifies interactions mediated by metabolic pathways as possible risk modifiers, supporting a precautionary approach for co-administration with other hepatotoxic agents or metabolic inhibitors.</p> </li> </ul>